Adjuvant Osimertinib Prolongs OS in Early-Stage EGFR-Mutated NSCLC
Patients with stage IB, II, or IIIA, EGFR-mutated non–small cell lung cancer derived benefit with adjuvant osimertinib.
DESTINY-Breast02 Confirms Benefit of Trastuzumab Deruxtecan in Previously Treated Patients With HER2+ Metastatic Breast Cancer
In the second-line setting, patients with advanced HER2-positive breast cancer derived a superior clinical benefit with trastuzumab deruxtecan compared with treatment with physician’s choice of treatment.
Equity, Diversity, and Inclusion in Oncology Nursing Leadership
For this episode of “The Vitals,” Aliènne Salleroli, MS, BSN, RN, OCN, discusses her research on equity, diversity, and inclusion in oncology nurse leadership.
Fewer Cycles of Oxaliplatin Treatment May Reduce Incidence of Severe Neuropathy for Patients With Stage III Colon Cancer
An observational study of 2450 patients with stage III colon cancer identified key factors that may increase a patient’s risk of oxaliplatin-induced peripheral neuropathy.
Adding Cediranib to Olaparib Increases Treatment Efficacy, But Raises Toxicity Concerns, in mCRPC
A regimen of cediranib and olaparib improved radiographic progression-free survival in patients with metastatic castration-resistant prostate cancer compared with olaparib monotherapy. However, the rate of dose reductions was doubled with the combination.
Oncology Therapy at the End of Life: Have We Missed the Mark?
"Over the last decade, the landscape of systemic anti-cancer therapy has changed dramatically following the approvals of multiple new targeted therapies," - Kerin Adelson, MD.
Aliènne Salleroli on Starting the DEI Conversation in Oncology Nursing
Aliènne Salleroli, MS, BSN, RN, OCN, underscores the importance of open dialogue surrounding diversity, equity, and inclusion in oncology leadership.
New Strategies Provide Faster Access To Cancer Care For Patients
Pilot programs based out of Yale Cancer Center and Moffitt Cancer Center seek to improve access for newly diagnosed patients with cancer.
How to Improve Nurse Responsiveness on an Inpatient Oncology Unit
An hourly rounding column helped make integrated data points more visible and improve nurse responsiveness on an inpatient floor.
Medication Extension Set Makes Subcutaneous Hyaluronidase Injections Easier, More Comfortable in Cancer Treatment
A medication extension set may be the preferred method for subcutaneous hyaluronidase injections compared with a traditional needle.
Brianna Lutz on How to Improve Nurse Responsiveness on an Inpatient Oncology Unit
Brianna Lutz, MSN, RN, OCN, discusses a red-and-green dot hourly column that shows which patients with cancer have been attended to in the past hour.
Established Downtime Procedures Protect Patient Outcomes Against Cyber Attacks
In the age of cyberattacks, establishing and practicing a downtime procedure is crucial to safeguard patient care, according to Kelli-Ann Mancini, MSN, RN, OCN.
Standardizing Venous Port Competency Among Non-Oncology Nurses Helps Reduce Delay Times for Patients with Cancer
Increasing the number of intravenous port nurse champions across a health care system helps to keep oncology nurses with their patients and reduce care delays.
Independent 2-Nurse Verification Process in Distribution of Oral Investigational Chemo/Immunotherapy Proves Helpful
Independent verification of documentation is paramount to patient safety.
Aliènne Salleroli on Establishing Equity, Diversity, and Inclusion Throughout Oncology Practice
The framework for establishing equity, diversity, and inclusion throughout oncology nursing already exists within the standard for health and safety, explains Aliènne Salleroli, MS, BSN, RN, OCN.
Telemedicine Use During COVID-19 Disparate Between White and Black Patients With Hematologic Cancers
The disparate use in telemedicine between White and Black patients warrants further exploration into compound cases, such as economic and societal factors.
Metastatic Urothelial Cancer Treatments Continue to Gravitate Towards Immunotherapy and Targeted Therapies
A Yale Cancer Center expert offers a quick glance at the metastatic urothelial cancer treatment landscape.
The Value of Nurse Mentorship in Oncology
In this episode of “The Vitals,” 2 veteran oncology nurses discuss the value of mentorship—particularly for novice nurses.
Allogeneic HSCT Elicits Favorable Outcomes in Myelofibrosis
Allogeneic hematopoietic stem cell transplant (HSCT) is still the sole curative therapeutic modality for patients with myelofibrosis.
Bypassing the SICU May Improve Patient Outcomes
Smilow Cancer Hospital tested sending patients directly from the post–anesthesia care unit (PACU) to the surgical oncology unit after head and neck surgery to reduce length of stay, postoperative complications, and readmission rates of patients.
Oncology Nurses in Fund-Raising
The call bell light in room 12-204 was the first to go off at the crack of dawn, breaking the serene silence of the floor. “I need to shower so I can see the race!” the patient exclaimed.
Message Delivered? Assessing the Effectiveness of Patient Education Interactions
Effective communication can impact patient outcomes, and the patient perspective is critical in assessing these professional communicational skills.
Mindfulness-Based Solutions for Healthcare Professionals
Smilow Cancer Hospital at Yale-New Haven took on a program to assess the effectiveness of mindfulness-based stress relief (MBSR) in patients with cancer.
Starting at "Zero" - Achieving Hospice and Palliative Care Certification
Leaders from Yale Smilow saw an opportunity to create an educational program to facilitate certification of inpatient and outpatient nurses in hospice and palliative care.
Urgent Visit Program Aims to Reduce ED Admissions
Educating, raising awareness, and implementing an urgent visit program can reduce emergency department use and number of hospitalizations.
Two, High-Dose Flu Shots Help High-Risk Patients Avoid Infection
Although patients with multiple myeloma and other plasma cell disorders (PCDs) are routinely vaccinated against influenza, studies show that a one-time flu shot does not confer an adequate immune response in these high-risk patients.
Helping Patients Tell Their Stories
"What's your opinion about using hair color?" I asked my doctor shortly before beginning chemotherapy. "I don't have an opinion," he said. "Talk to one of the nurses."
Mark Lazenby on Psychosocial Topics Concerning APOS
Mark Lazenby, PhD, APRN, FAPOS, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses psychosocial topics that concern APOS.
Mark Lazenby on Universality of Psychosocial Concerns Following Cancer Diagnosis
Mark Lazenby, PhD, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses the universality of psychosocial concerns following a cancer diagnosis.
Psychosocial Distress Screenings Essential to Patient-Centered Care
The American Psychosocial Oncology Society (APOS) partnered with Yale School of Nursing to launch the Screening for Psychosocial Distress Program in 2014.
Olanzapine Significantly Reduces CINV in Patients Receiving MEC
Reimagining Frailty Screenings in Head and Neck Cancer
Screening for Pain and Depression is Not Enough in Cancer Care
Niraparib-Based Triplet Therapy Offers OS Advantage in BRCA1/2+ mCRPC
2 Clarke Drive Cranbury, NJ 08512